JPRN-UMIN000006575已完成2 期
CLINICAL EVALUATION OF NEW TERUMO DRUG ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE - CENTURY Study
Terumo Europe N.V.0 个研究点目标入组 100 人开始时间: 2011年10月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Most recent LVEF is < 25% 2) Known allergies to aspirin, Clopidogrel bisulfate, Prasugrel or Ticlopidine, heparin, cobalt, chromium, nickel, or contrast agent or Sirolimus 3) A platelet count is < 100K or > 700K 4) WBC count is < 3.5K 5) Evidence of an ST-segment elevation acute MI or Non-ST segment elevation MI with positive Troponin within 72h of the intended treatment 6) Previous PCI 7) Presence of any other significant lesion of > 50% stenosis anywhere within the target vessel (TV) 8) Significant lesions in any non-TV that will require interventional treatment, within 30 days post-procedure 9) Planned future interventional procedure in the TV is not allowed 10) The target lesions requires treatment with a device other than PTCA balloon prior to stent placement 11) Previous stenting anywhere within the TVs 12) TV has evidence of thrombus 13) Excessive tortuousity of the TV proximal to the target lesion (TL) 14) Either of the following characteristics in the TLs a) Ostial TL or bifurcation lesion b) TL involves a side branch c) TL has excessive tortuousity d) Moderate to severely calcified lesion which can not be successfully predilated e) TL is located in or supplied by an arterial or venous bypass graft f) Significant stenosis proximal or distal to the TL g) A complete occlusion 15) TL is located in left main trunk. 16) Stroke or transient ischemic attack within the prior 180d 17) Active peptic ulcer or upper GI bleeding within the prior 180d 18) The PT (patient) has bleeding hemorrhagic diathesis or coagulopathy. 19) The PT will refuse a blood transfusion 20) The PT has a widespread peripheral vascular disease 21) Acute or chronic renal dysfunction 22) The PT requires multiple stent implantations for a tandem lesion 23) Life expectancy <1Y 24) PT is currently participating in other clinical studies 25) In the investigators opinion PT has co-morbid conditions that could limit the PTs ability to participate in the study 26) PT in cardiogenic shock 27) Female of child-bearing potential
研究者
相似试验
已完成
3 期
CLINICAL EVALUATION OF NEW TERUMO DRUG ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASEIschemic heart diseaseJPRN-UMIN000006940Terumo Europe N.V.1,120
已完成
3 期
Clinical Evaluation of New Terumo drug elUting coRonary stent system in the treatment of patients with coronarY artery disease in Small Vessels in Japanese populatioIschemic heart diseaseJPRN-UMIN000012928Terumo Corporation70
已完成
4 期
Evaluation of the efficacy of Tetonal drug in comparison with Meloxicam on pain relief and functional improvent of patient with knee osteoartheritisKnee osteoartheritis.IRCT20191031045291N1Shiraz university of medical sciences30
已完成
不适用
The clinical trial for safety and efficacy of chronic hepatitis therapeutics agent, 3-oxygelmillpropionic acid polymer for pancreatic cancer (Phase 1)Resectable pancreatic cancerJPRN-UMIN000027441Osaka University10
已完成
1 期
Mesenchymal Stem Cells Transplantation in newly diagnosed Type-1 Diabetes PatientsDiabetes.Insulin-dependent diabetes mellitusIRCT2016070428786N1Royan Institute20